scholarly journals Disease severity and proton pump inhibitor use impact strongest on faecal microbiome composition in liver cirrhosis

2020 ◽  
Vol 40 (4) ◽  
pp. 866-877 ◽  
Author(s):  
Vanessa Stadlbauer ◽  
Irina Komarova ◽  
Ingeborg Klymiuk ◽  
Marija Durdevic ◽  
Alexander Reisinger ◽  
...  
Keyword(s):  
Liver Cirrhosis ◽  
Proton Pump Inhibitor ◽  
Disease Severity ◽  
Proton Pump ◽  
Microbiome Composition ◽  
Faecal Microbiome

Disease severity and proton pump inhibitor use impacts strongest on faecal microbiome composition in cirrhosis

2020 ◽  
Vol 73 ◽  
pp. S235-S236
Author(s):  
Vanessa Stadlbauer ◽  
Irina Komarova ◽  
Ingeborg Klymiuk ◽  
Marija Durdevic ◽  
Alexander Reisinger ◽  
...  
Keyword(s):  
Proton Pump Inhibitor ◽  
Disease Severity ◽  
Proton Pump ◽  
Microbiome Composition ◽  
Faecal Microbiome

scholarly journals Disappearance of Gastric Hyperplastic Polyps after the Discontinuation of Proton Pump Inhibitor in a Patient with Liver Cirrhosis

2021 ◽  
pp. 202-209
Author(s):  
Kengo Yasugi ◽  
Ken Haruma ◽  
Miwa Kawanaka ◽  
Mitsuhiko Suehiro ◽  
Jun Nakamura ◽  
...  
Keyword(s):  
Liver Cirrhosis ◽  
Proton Pump Inhibitor ◽  
Proton Pump ◽  
Upper Gastrointestinal Endoscopy ◽  
Complete Disappearance ◽  
Hyperplastic Polyps ◽  
Cell Hyperplasia ◽  
Greater Curvature ◽  
One Year ◽  
Epithelium Cells

Here, we report on a rare case of gastric hyperplastic polyps which disappeared after the discontinuation of proton pump inhibitor (PPI). The patient was an 83-year-old woman with liver cirrhosis and portal hypertension, along with gastroesophageal reflux disease treated by PPI. An initial upper gastrointestinal endoscopy showed unique polypoid lesions in the greater curvature of the stomach. Biopsy specimens of the lesions were diagnosed as hyperplastic polyps and she was followed. One year later, a second endoscopy showed that the lesions had increased in number and size, and an endoscopic mucosal resection (EMR) was performed for the main polyps. The resected specimens indicated a proliferation of foveolar epithelium cells with an increase of capillary ectasia and parietal cell hyperplasia, which was thought to be induced by hypergastrinemia from the PPI. Three months after the EMR, she was admitted because of bleeding from the remaining polyps along with an increase in new polyps. After conservative treatment, PPI was stopped and rebamipide was used. One year and 6 months later, an endoscopy showed the complete disappearance of all gastric polyps.

scholarly journals Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis

2019 ◽  
Vol 25 (33) ◽  
pp. 4933-4944 ◽  
Author(s):  
Marianne Anastasia De Roza ◽  
Lim Kai ◽  
Jia Wen Kam ◽  
Yiong Huak Chan ◽  
Andrew Kwek ◽  
...  
Keyword(s):  
Liver Cirrhosis ◽  
Proton Pump Inhibitor ◽  
Proton Pump ◽  
Hepatic Decompensation

scholarly journals Proton pump inhibitor use is associated with a variety of infections in patients with liver cirrhosis

Medicine ◽  
2020 ◽  
Vol 99 (50) ◽  
pp. e23436
Author(s):  
Christian Labenz ◽  
Karel Kostev ◽  
Peter R. Galle ◽  
Marcus-Alexander Wörns ◽  
Joachim Labenz ◽  
...  
Keyword(s):  
Liver Cirrhosis ◽  
Proton Pump Inhibitor ◽  
Proton Pump

scholarly journals Proton Pump Inhibitor Use is Associated with Spontaneous Bacterial Peritonitis in Patients with Liver Cirrhosis

2014 ◽  
Vol 53 (10) ◽  
pp. 1037-1042 ◽  
Author(s):  
Kotaro Miura ◽  
Atsushi Tanaka ◽  
Takatsugu Yamamoto ◽  
Meguru Adachi ◽  
Hajime Takikawa
Keyword(s):  
Liver Cirrhosis ◽  
Proton Pump Inhibitor ◽  
Proton Pump ◽  
Spontaneous Bacterial Peritonitis ◽  
Bacterial Peritonitis
Sign in / Sign up

Export Citation Format

Share Document